Broadview Investments Revenue, Growth & Competitor Profile

DBA BROADVIEW INVESTMENT LLC

Company Profile & Annual Report for Broadview Investments

Access the complete profile.

Broadview Investments Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Address	545 Old Elbert Rd Royston, GA 30662

Note: Revenues for privately held companies are statistical evaluations.


Broadview Investments's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Broadview Investments's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Broadview Investments is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Broadview Investments Annual Revenue and Growth Rate

Broadview Investments	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Broadview Investments's revenues are gauged from an analysis of company filings.

Broadview Investments's Income Statement (based on Industry Averages)

Broadview Investments P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Broadview Investments is developing and marketing. Broadview Investments doesn't have any recent trademark applications, indicating Broadview Investments is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PHARMA TECH INDUSTRIES WE MAKE PRODUCTSTHAT FULFILL PROMISES Contract manufacturing for the pharmaceutical and health and beauty aids industries	05/04/2015
OUTSOURCING DONE RIGHT. Contract manufacturing for the pharmaceutical and health and beauty aids industries	07/28/2009
PTI PHARMA TECH INDUSTRIES OUTSOURCING DONE RIGHT. Contract manufacturing for the pharmaceutical and health and beauty aids industries	07/28/2009

See all trademarks and details in the Full Report.

Market Share of Broadview Investments's Largest Competitors

A competitive analysis shows these companies are in the same general field as Broadview Investments, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Broadview Investments. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PHARMA TECH INDUSTRIES	Royston, GA	100
BROADVIEW INVESTMENTS	Royston, GA	98
WINDER LABORATORIES	Winder, GA	13
RPEPTIDE	Watkinsville, GA	3
ATHENS RESEARCH & TECHNOLOGY	Athens, GA	1

Future Competition: Broadview Investments's Fastest Growing Competitors

These companies are in the same general field as Broadview Investments and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)